Uzbekistan eyes Indian pharma firms to achieve $10 bn output by 2035

The Central Asian nation is offering tax breaks, infrastructure support and regulatory incentives as it seeks to become a pharmaceutical manufacturing hub for the CIS region

Go to News Site